Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug;38(4):1394-400.
doi: 10.1007/s10753-015-0113-5.

Ebselen Attenuates Lung Injury in Experimental Model of Carrageenan-Induced Pleurisy in Rats

Affiliations

Ebselen Attenuates Lung Injury in Experimental Model of Carrageenan-Induced Pleurisy in Rats

Fabricia Petronilho et al. Inflammation. 2015 Aug.

Abstract

The study evaluates the role of Ebselen (Eb), an organoselenium compound in animal model of acute lung injury induced by carrageenan (CG). Wistar rats received saline or 2 % λ-carrageenan in the pleural cavity, and treatment with Eb (50 mg/kg intragastrically) or dexamethasone (Dx) (0.5 mg/kg intraperitoneal) after CG administration. After 4 h, rats were euthanized and the pleural exudate removed for analysis of the total cell count, total protein, lactate dehydrogenase, and nitrite/nitrate. Moreover, lung tissue were removed to verify the myeloperoxidase activity and oxidative damage. Eb showed anti-inflammatory activity by inhibiting leukocyte influx, myeloperoxidase activity, and nitrite/nitrate concentration. Eb presented with an anti-inflammatory activity similar to Dx and an antioxidant activity better than Dx. This study suggests that Eb plays an important role against the oxidative damage associated with anti-inflammatory activity in animal model of acute lung injury, proving to be similar or potentially more effective than Dx.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Antioxid Redox Signal. 2007 Nov;9(11):1991-2002 - PubMed
    1. Biochem Pharmacol. 1984 Oct 15;33(20):3241-5 - PubMed
    1. Mol Pharmacol. 2004 Sep;66(3):683-93 - PubMed
    1. Agents Actions. 1989 Mar;26(3-4):335-41 - PubMed
    1. J Pharmacol Exp Ther. 1995 Jun;273(3):1295-9 - PubMed

LinkOut - more resources